The roles of proteinase-activated receptors in the vascular physiology and pathophysiology

被引:124
作者
Hirano, Katsuya [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Angiocardiol Res Inst, Div Mol Cardiol, Fukuoka 8128582, Japan
关键词
thrombin; receptors; vascular biology; endothelium; smooth muscle;
D O I
10.1161/01.ATV.0000251995.73307.2d
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Proteinase-activated receptors (PARs) belong to a family of G protein-coupled receptors, thus mediating the cellular effects of proteinases. In the vascular system, thrombin and other proteinases in the coagulation-fibrinolysis system are considered to be the physiologically relevant agonists, whereas PARs are among the most important mechanisms mediating the interaction between the coagulation - fibrinolysis system and the vascular wall. Under physiological conditions, PARs are mainly expressed in endothelial cells, and participate in the regulation of vascular tone, mostly by inducing endothelium-dependent relaxation. PARs in endothelial cells are also suggested to contribute to a proinflammatory phenotypic conversion and an increase in the permeability of vascular lesions. In smooth muscle cells, PARs mediate contraction, migration, proliferation, hypertrophy, and production of the extracellular matrix, thereby contributing to the development of vascular lesions and the pathophysiology of such vascular diseases as atherosclerosis. However, the expression of PARs in the smooth muscle of normal arteries is limited. The upregulation of PARs in the smooth muscle is thus considered to be a key step for PARs to participate in the pathogenesis of vascular lesions. Elucidating the molecular mechanism regulating the PARs expression is therefore important to develop new strategies for the prevention and treatment of vascular diseases.
引用
收藏
页码:27 / 36
页数:10
相关论文
共 136 条
[1]
Inhibition of cellular action of thrombin by N3-cyclopropyl-7-{[4-(1-methylethyl)phenyl]methyl}-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist [J].
Ahn, HS ;
Foster, C ;
Boykow, G ;
Stamford, A ;
Manna, M ;
Graziano, M .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (10) :1425-1434
[2]
Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[3]
Activation of RhoA by thrombin in endothelial hyperpermeability - Role of Rho kinase and protein tyrosine kinases [J].
Amerongen, GPV ;
van Delft, S ;
Vermeer, MA ;
Collard, JG ;
van Hinsbergh, VWM .
CIRCULATION RESEARCH, 2000, 87 (04) :335-340
[4]
Andrade-Gordon P, 2001, J PHARMACOL EXP THER, V298, P34
[5]
CHROMOSOMAL ASSIGNMENT OF THE HUMAN THROMBIN RECEPTOR GENE - LOCALIZATION TO REGION Q13 OF CHROMOSOME-5 [J].
BAHOU, WF ;
NIERMAN, WC ;
DURKIN, AS ;
POTTER, CL ;
DEMETRICK, DJ .
BLOOD, 1993, 82 (05) :1532-1537
[6]
Protease activated receptors in cardiovascular function and disease [J].
Barnes, JA ;
Singh, S ;
Gomes, AV .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 263 (01) :227-239
[7]
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells [J].
Boire, A ;
Covic, L ;
Agarwal, A ;
Jacques, S ;
Sherifl, S ;
Kuliopulos, A .
CELL, 2005, 120 (03) :303-313
[8]
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa [J].
Camerer, E ;
Huang, W ;
Coughlin, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5255-5260
[9]
Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells [J].
Camerer, E ;
Kataoka, H ;
Kahn, M ;
Lease, K ;
Coughlin, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) :16081-16087
[10]
Roles of protease-activated receptors in a mouse model of endotoxemia [J].
Camerer, Eric ;
Cornelissen, Ivo ;
Kataoka, Hiroshi ;
Duong, Daniel N. ;
Zheng, Yao-Wu ;
Coughlin, Shaun R. .
BLOOD, 2006, 107 (10) :3912-3921